JP Morgan Chase
MENS

JP Morgan Chase’s Jyong Biotech MENS Stock Holding History

JP Morgan Chase’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Sell
5,379
-300
-5% -$636 ﹤0.01% 6872
2026
Q1 		$10.8K Sell
5,679
-372
-6% -$910 ﹤0.01% 6718
2025
Q4 		$23.9K Buy
+6,051
New +$214K ﹤0.01% 6460

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's MENS Position: Q2 2026 in Review

JP Morgan Chase reduced its Jyong Biotech (MENS) stake by 5.3% in Q2 2026, selling an estimated $636 and leaving 5,379 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6872.

JP Morgan Chase first reported a position in MENS in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.9K in Q4 2025. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • JP Morgan Chase held 5,379 shares of Jyong Biotech worth $11.8K as of Q2 2026.
  • JP Morgan Chase sold 300 Jyong Biotech shares in Q2 2026, an estimated $636.
  • Jyong Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6872 holding.
  • JP Morgan Chase first reported a position in Jyong Biotech in Q4 2025 and has held it in 3 quarters since.
  • JP Morgan Chase's Jyong Biotech position peaked at $23.9K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.